Preferential measures on bioequivalence-proven items eyed

Published: 2003-01-03 06:59:00

Updated: 2003-01-03 06:59:00

The Ministry of Health and Welfare (MOHW) announced on December 31 that it revised the calculation criteria of drug ceiling price (Attachment No. 1) concerning the determination and adjustment of new medical technology, to this effect that the prices of bioequivalence-accredited copy products, as...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK